2m 2m 2m 2m 2m 2m 2m
Theravance Bioph (TBPH)
NASDAQ
$16.87+$0.01 (+0.08%)
Price as of Aug 03, 2026 8:01 AM EDT- $1.2BMarket Cap
- 54.68%1-Year Change
- BiotechnologyIndustry
Theravance Bioph (TBPH)
$16.87+$0.01 (+0.08%)
TBPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.86 | ||
Change | +$0.010 (+0.06%) | ||
Open | $16.87 | ||
High | $16.88 | ||
Low | $16.85 | ||
Previous Close | $16.85 | ||
Volume | 369,695 | ||
30-Day Average Volume | 677,362 | ||
1-Week Change | 0.00% | ||
1-Month Change | -0.82% | ||
1-Year Change | 54.68% | ||
3-Year Change | 70.48% | ||
5-Year Change | 29.89% | ||
Fundamentals | |||
Shares Outstanding | 73.5M | ||
Total Assets | $472.3M | ||
Market Cap | $1.2B | ||
Enterprise Value | $950.6M | ||
Period: QTR TTM FY | |||
Revenue | $17.7M | ||
Net Income | -$4.9M | ||
Free Cash Flow | $73.3M | ||
EBIT | -$6.5M | ||
EBITDA | -$6.1M | ||
Net Working Capital | $385.9M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -156 | ||
Enterprise Value/Revenue | 54 | ||
P/B | 4 | ||
P/E | -169 | ||
PEG | 2 | ||
Price/Free Cash Flow | 17 | ||
Price/Operating Cash Flow | 17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue